A structured population model of clonal selection in acute leukemias with multiple maturation stages by Lorenzi, Tommaso et al.
Noname manuscript No.
(will be inserted by the editor)
A structured population model of clonal selection in
acute leukemias with multiple maturation stages
Tommaso Lorenzi · Anna
Marciniak-Czochra · Thomas Stiehl
Received: date / Accepted: date
Abstract Recent progress in genetic techniques has shed light on the complex
co-evolution of malignant cell clones in leukemias. However, several aspects
of clonal selection still remain unclear. In this paper, we present a multi-
compartmental continuously structured population model of selection dynam-
ics in acute leukemias, which consists of a system of coupled integro-differential
equations. Our model can be analysed in a more efficient way than classical
models formulated in terms of ordinary differential equations. Exploiting the
analytical tractability of this model, we investigate how clonal selection is
shaped by the self-renewal fraction and the proliferation rate of leukemic cells
at different maturation stages. We integrate analytical results with numerical
solutions of a calibrated version of the model based on real patient data. In
summary, our mathematical results formalise the biological notion that clonal
selection is driven by the self-renewal fraction of leukemic stem cells and the
clones that possess the highest value of this parameter are ultimately selected.
Moreover, we demonstrate that the self-renewal fraction and the proliferation
rate of non-stem cells do not have a substantial impact on clonal selection.
Taken together, our results indicate that interclonal variability in the self-
renewal fraction of leukemic stem cells provides the necessary substrate for
clonal selection to act upon.
Tommaso Lorenzi
School of Mathematics and Statistics, University of St Andrews, North Haugh, St Andrews,
Fife, KY16 9SS, United Kingdom
E-mail: tl47@st-andrews.ac.uk
Anna Marciniak-Czochra
Institute of Applied Mathematics, BIOQUANT and IWR, Im Neuenheimer Feld 205, Hei-
delberg University, 69120 Heidelberg, Germany
E-mail: Anna.Marciniak@iwr.uni-heidelberg.de
Thomas Stiehl
Institute of Applied Mathematics, Im Neuenheimer Feld 205, Heidelberg University, 69120
Heidelberg, Germany
E-mail: thomas.stiehl@iwr.uni-heidelberg.de
ar
X
iv
:1
90
7.
02
84
2v
1 
 [m
ath
.A
P]
  5
 Ju
l 2
01
9
2 Tommaso Lorenzi et al.
Keywords Acute leukemia · Clonal selection · Continuously structured
population models · Integro-differential equations · Asymptotic analysis
1 Introduction
Statement of the biological problem. Leukemias are malignant diseases of
the hematopoietic system. Similarly to the healthy hematopoietic system, the
leukemic cell bulk is organised as a hierarchy of multiple maturation stages
(i.e. maturation compartments) – from stem cells through a number of in-
creasingly mature progenitor cells to the most mature cells (Bonnet and Dick,
1997; Hope et al., 2004). Red blood cells, white blood cells and platelets con-
stitute the most mature compartment of healthy cells, whereas non-functional
leukemic blasts are the most mature leukemic cells. The extensive growth of
non-functional leukemic blasts leads to impaired hematopoiesis and causes a
shortage of healthy blood cells.
In contrast to the most mature cells, which do not divide and die at a con-
stant rate, stem and progenitor cells can proliferate and give rise to progeny
cells which are either at the same maturation stage as their parent (self-
renewal) or at a subsequent maturation stage (differentiation). These processes
can be quantitatively characterised in terms of two parameters: the cell prolif-
eration rate, i.e. the number of cell divisions per unit of time, and the cell self-
renewal fraction, i.e. the probability that a progeny adopts the same cell fate
as its parent (Marciniak-Czochra et al., 2009; Stiehl and Marciniak-Czochra,
2012). There is both theoretical (Stiehl et al., 2015) and experimental (Jung
et al., 2015; Metzeler et al., 2013; Wang et al., 2017) evidence suggesting that
the proliferation rate and the self-renewal fraction of leukemic cells have a
significant impact on the disease dynamics and on patient prognosis (Stiehl
and Marciniak-Czochra, 2017).
The collection of all stem, progenitor and most mature cells which carry the
same set of genetic alterations defines a leukemic clone. Recent experimental
evidence indicates that the leukemic cell bulk of an individual patient is com-
posed of multiple clones carrying different mutations (Anderson et al., 2011;
Ding et al., 2012; Ley et al., 2008) and having different functional properties,
among which different proliferation rates and self-renewal fractions (Eppert
et al., 2011; Heuser et al., 2009). Such clonal heterogeneity poses a major ob-
stacle to successful therapy and management of disease relapse (Choi et al.,
2007; van Delft et al., 2011; Lutz et al., 2013a,b). In fact, it has been reported
that in many cases of acute lymphoblastic leukemias (ALL) and acute myeloid
leukemias (AML) relapse is triggered by the selection of clones that have been
present as minor (small) clones at the time of diagnosis rather than by newly
acquired mutations (Choi et al., 2007; van Delft et al., 2011; Ding et al., 2012;
Jan and Majeti, 2013).
It is becoming increasingly apparent that clonal heterogeneity results from
a selection process at the cellular level which triggers the expansion of some
clones and the out-competition of others (Belderbos et al., 2017; Choi et al.,
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2007; Hirsch et al., 2016; Noetzli et al., 2017; Stiehl et al., 2014a; Wu et al.,
2017). However, several aspects of clonal selection are so far not well under-
stood and a number of important questions remain open (Stiehl and Marciniak-
Czochra, 2019). In this paper, we focus on clonal selection taking place before
diagnosis or relapse of acute leukemias. We use a mathematical modelling
approach to address the following questions:
Q1 What is the role of the proliferation rate and the self-renewal fraction of
leukemic cells in clonal selection?
Q2 Can we observe clonal selection among clones that have identical stem-
cell properties (in terms of proliferation rate and self-renewal fraction) and
differ in their progenitor-cell properties?
Q3 What are the necessary conditions (in terms of proliferation rate and self-
renewal fraction) for the long-term coexistence of different clones?
Mathematical framework. A well-established mathematical approach to
describing the dynamics of multiple leukemic clones is to use models with
multiple compartments formulated in terms of ordinary differential equations
(ODEs) (Stiehl et al., 2014a; Werner et al., 2013). In these models, every cell
is characterised by a pair of indices i = 1, . . . ,M and j = 0, . . . , J . The index i
corresponds to the maturation stage of the cell (i.e. the compartment to which
the cell belongs). The index j = 1, . . . , J indicates what leukemic clone the cell
belongs to, whilst the index j = 0 is conventionally associated to healthy cells.
In this modelling framework, a collection of parameters pji and a
j
i is introduced
to model, respectively, the proliferation rate and the self-renewal fraction of
cells of clone j = 1, . . . , J at the maturation stage i = 1, . . . ,M − 1. Clonal
heterogeneity is incorporated into the model by allowing the values of these
parameters to change from one clone to the other. The dynamic of every clone
is described by a system of M coupled ODEs that track the time evolution
of the density of cells at different maturation stages. An additional system of
M coupled ODEs is introduced to model the dynamic of the healthy cells.
Coherently with biological findings (Kondo et al., 1991; Layton et al., 1989;
Shinjo et al., 1997), all ODEs of the model are coupled through a feedback
signal that regulates the cell dynamics and depends on the total density of
cells at the maturation stage M (i.e. all the most mature healthy and leukemic
cells). A prototypical version of such ODE models can be found in Appendix A
of this paper.
These models consist of systems of (J + 1)M coupled ODEs. Due to the
high degree of clonal heterogeneity usually observed in leukemia patients, the
biologically realistic values of J can be very high. As a result, the analysis
of these models becomes very hard (if not impossible) in scenarios that are
clinically relevant. This poses limitations to the robustness of the biological
conclusions that can be obtained using these models. To overcome these limi-
tations, here we present a modelling framework whereby the index j is replaced
by a continuous structuring variable x. This variable can be seen as a parame-
terisation of the self-renewal fraction and the proliferation rate of the different
clones. Hence, in our modelling framework the parameters pji and a
j
i of the
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ODE model are replaced by some functions pi(x) and ai(x) which represent,
respectively, the proliferation rate and the self-renewal fraction of cells that
are at the maturation stage i and belong to the clone identified by the vari-
able x. This multi-compartmental continuously structured population model
consists of a system of M coupled integro-differential equations (IDEs) that
can be analysed in a more efficient way than its ODE counterpart.
Main results of this paper. Exploiting the analytical tractability of the
model, we address questions Q1-Q3 listed above by elucidating how clonal
selection is shaped by the self-renewal fraction and the proliferation rate of
leukemic cells at different maturation stages. Analytical results are integrated
with numerical solutions of a calibrated version of the model based on patient
data from the existing literature. In summary, our results formalise the idea
that clonal selection is controlled by the self-renewal fraction of leukemic stem
cells and the clones with the highest value of this parameter are ultimately
selected. This implies that only the clones whose stem cells are characterised by
the highest self-renewal fraction can stably coexist. Finally, our results indicate
that interclonal variability in the self-renewal fraction of leukemic stem cells
provides the necessary substrate for clonal selection to act upon.
Our analytical work follows earlier papers on the asymptotic analysis of
IDEs that arise in the mathematical modelling of selection dynamics in pop-
ulations structured by physiological traits (Barles et al., 2009; Busse et al.,
2016; Calsina et al., 2013; Chisholm et al., 2016; Delitala and Lorenzi, 2012;
Desvillettes et al., 2008; Diekmann et al., 2005; Lorenzi et al., 2014; Lorz
et al., 2011; Perthame and Barles, 2008; Raoul, 2011). In particular, Busse
et al. (2016) have studied a basic version of the model, in which only two mat-
uration stages are considered (i.e. M = 2) and all the clones have the same
cell proliferation rate, i.e. the functions p1(x), . . . , pM−1(x) are constant. The
main novelty of our work is that we let the number of maturation stages M be
arbitrarily large and we allow the cell proliferation rate to vary from clone to
clone, i.e. the functions p1(x), . . . , pM−1(x) are not necessarily constant. This
makes the application domain of our results significantly wider and strength-
ens the robustness of our biological conclusions. Due to these additional layers
of complexity, our analysis builds on a method of proof which is different from
that proposed by Busse et al. and is based on asymptotic arguments related
to those proposed by Desvillettes et al. in (Desvillettes et al., 2008). We re-
mark that our analytical results rely on general assumptions and, therefore,
are applicable to different subtypes of leukemia.
2 Description of the model
We present a multi-compartmental continuously structured population model
for the dynamics of cells of multiple leukemic clones and healthy cells at dif-
ferent maturation stages. The model is given by the system of IDEs (5) and
is defined as a continuous version of the multi-compartmental ODE model
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presented in (Stiehl et al., 2014a) – for the sake of completeness, we provide
a short description of such an ODE model in Appendix A – and a generali-
sation of the continuously-structured population model with two maturation
compartments considered in (Busse et al., 2016). The key ideas underlying our
model are summarised by the schematic diagrams in Fig. 1.
As illustrated by the scheme in Fig. 1(B), we capture the high degree of
clonal heterogeneity usually observed in leukemia patients by introducing a
continuous structuring variable x ∈ [0, 1], and we assume that x = 0 corre-
sponds to healthy cells whereas different leukemic clones are characterised by
different values of x ∈ (0, 1]. At time t ∈ [0, T ], where T > 0 is an arbitrary
final time, the population densities of stem cells (compartment i = 1), increas-
ingly mature progenitor cells (compartments i = 2, . . . ,M − 1), and mature
cells and leukemic blasts (compartment i = M) are represented by the func-
tions ni(t, x) ≥ 0. At every time instant t, the total density of cells at the i-th
maturation stage is defined as
ρi(t) :=
∫ 1
0
ni(t, x) dx with i = 1, . . . ,M. (1)
As illustrated by the scheme in Fig. 1(A), mature cells and leukemic blasts
do not divide and die at a constant rate d > 0. Moreover, we use the functions
pi(x) and ai(x) to model, respectively, the proliferation rate and the self-
renewal fraction of cells of clone x at the maturation stage i = 1, . . . ,M − 1.
The flux to mitosis of cells of clone x at the maturation stage i = 1, . . . ,M −
1 at time t is given by ni(t, x) pi(x). These ni(t, x) pi(x) cells divide into
2ni(t, x) pi(x) offspring cells. The fraction ai(x) s(t) of the offspring cells is
at the maturation stage i (self-renewal), while the fraction 1− ai(x) s(t) is at
the maturation stage i + 1 (differentiation). The factor s(t) models the con-
centration of feedback signal that promotes the self-renewal of dividing cells
and is absorbed by mature cells and leukemic blasts. In agreement with the
biological findings presented in (Kondo et al., 1991; Layton et al., 1989; Shinjo
et al., 1997), we let s(t) be a monotonically decreasing function of ρM (t). In
particular, we use the definition s(t) = 11+KρM (t) , where the parameter K > 0
is related to the degradation rate of the feedback signal (Marciniak-Czochra
et al., 2009; Stiehl et al., 2014c; Stiehl and Marciniak-Czochra, 2011, 2012).
Such a definition can be derived from an ODE for s(t) using a quasi-stationary
approximation (Getto et al., 2013; Marciniak-Czochra et al., 2018).
Throughout the paper, we assume
ai ∈W1,∞ ([0, 1]) with ai : [0, 1]→
(
1
2
, 1
)
for all i = 1, . . . ,M − 1, (2)
pi ∈W1,∞ ([0, 1]) with pi : [0, 1]→ (0, 1) for all i = 1, . . . ,M − 1, (3)
1
2
< ai(x) < a1(x) < 1 for all x ∈ [0, 1], for all i = 2, . . . ,M − 1. (4)
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Fig. 1: Schematic overview of the model. (A) Processes at the cellular
level and their mathematical description (B) Multi-compartmental continu-
ously structured population model. For each maturation compartment i, dif-
ferent leukemic clones are characterised by different values of the continuous
variable x ∈ (0, 1], whereas x = 0 corresponds to healthy cells. All compart-
ments are coupled through the feedback signal s(t). Proliferation, self-renewal
and differentiation of cells are modelled as schematised in panel (A).
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Assumptions (2)-(4) rely on the following biological considerations. It has been
shown that the self-renewal fraction of stem cells has to be larger than 12
to allow for cell expansion (Stiehl and Marciniak-Czochra, 2011, 2012). This
justifies assumption (2) for i = 1. Moreover, we justify assumptions (2) for
i = 2, . . . ,M − 1 on the basis of biological evidence indicating that progenitor
cells at different maturation stages are able to expand with little or no influx
from the stem-cell compartment (Roelofs et al., 2003; Yamamoto et al., 2013).
Previous experimental and theoretical studies (Hope et al., 2004; Reya et al.,
2001; Stiehl and Marciniak-Czochra, 2011) have shown that stem cells have
a higher self-renewal fraction than the progenitor cells to which they give
rise. This justifies assumption (4). Furthermore, the cellular proliferation rates
are bounded from above due to the time required by genome replication. A
reasonable upper bound is between 1 and 2 divisions per day (Morgan et al.,
2007), from which one can deduce assumptions (3).
The evolution of the cell population density functions ni(t, x) is governed
by the following system of coupled IDEs
∂
∂t
n1(t, x) =
(
2 a1(x)
1 +KρM (t)
− 1
)
p1(x)n1(t, x),
∂
∂t
ni(t, x) = 2
(
1− ai−1(x)
1 +KρM (t)
)
pi−1(x)ni−1(t, x)
+
(
2 ai(x)
1 +KρM (t)
− 1
)
pi(x)ni(t, x), i = 2, . . . ,M − 1,
∂
∂t
nM (t, x) = 2
(
1− aM−1(x)
1 +KρM (t)
)
pM−1(x)nM−1(t, x)− dnM (t, x),
ρM (t) =
∫ 1
0
nM (t, x) dx,
(5)
subject to the initial conditions below
ni(0, x) = n
0
i (x) ∈ C([0, 1]), 0 < n0i <∞ on [0, 1] for i = 1, . . . ,M, (6)
which correspond to a biologically consistent scenario where numerous leukemic
clones are present at the time of diagnosis.
3 Analysis of clonal selection
We prove a general asymptotic result (vid. Section 3.1) that sheds light on
the way in which the self-renewal fraction and the proliferation rate of cells at
different maturation stages impact on clonal selection (vid. Section 3.2).
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3.1 A general asymptotic result
Building on previous studies on the long-time behaviour of continuously struc-
tured population models (Barles et al., 2009; Chisholm et al., 2016; Desvillettes
et al., 2008; Diekmann et al., 2005; Lorz et al., 2011; Perthame and Barles,
2008), we introduce a small parameter ε > 0 and use the time scaling t 7→ tε ,
so that considering the asymptotic regime ε→ 0 is equivalent to studying the
behaviour of the solutions to the IDEs of the model over many cell genera-
tions. With this scaling, the Cauchy problem for the cell population density
functions ni
(
t
ε , x
)
= niε(t, x) reads as
ε
∂
∂t
n1ε(t, x) = P1(ρMε(t), x)n1ε(t, x),
ε
∂
∂t
niε(t, x) = Qi−1(ρMε(t), x)ni−1ε(t, x)
+ Pi(ρMε(t), x)niε(t, x), i = 2, . . . ,M − 1,
ε
∂
∂t
nMε(t, x) = QM−1(ρMε(t), x)nM−1ε(t, x)− dnMε(t, x),
ρMε(t) =
∫ 1
0
nMε(t, x) dx,
niε(0, x) = n
0
i (x), i = 1, . . . ,M,
(7)
where
Pi(ρMε, x) :=
(
2 ai(x)
1 +KρMε
− 1
)
pi(x) for i = 1, . . . ,M − 1
and
Qi(ρMε, x) := 2
(
1− ai(x)
1 +KρMε
)
pi(x) for i = 1, . . . ,M − 1.
Throughout this section we use the notation
ρiε(t) :=
∫ 1
0
niε(t, x) dx with i = 1, . . . ,M
and
Riε(t, x) :=
∫ t
0
Pi(ρMε(s), x) ds for i = 1, . . . ,M − 1. (8)
A general result on the asymptotic behaviour of the cell population density
functions niε(t, x) for ε → 0 (i.e. in the limit of many cell generations) is
established by Theorem 1.
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Theorem 1 (A general asymptotic result) Under assumptions (2)-(4)
and (6), the solutions to the Cauchy problem (7) are such that, up to extraction
of subsequences,
niε −−−⇀
ε→0
ni on w
∗ − L∞ ((0, T ),M1([0, 1])) for i = 1, . . . ,M (9)
and
Riε −−−→
ε→0
Ri uniformly in [0, T ]× [0, 1] for i = 1, . . . ,M − 1, (10)
where
Ri(t, x) :=
∫ t
0
Pi(ρM (s), x) ds and Ri ∈W1,∞ ((0, T )× [0, 1]) . (11)
Moreover, the limits Ri are such that
max
x∈[0,1]
R1(t, x) = 0 for any t ∈ [0, T ] (12)
and
max
x∈[0,1]
Ri(t, x) < 0 for any t ∈ [0, T ], for i = 2, . . . ,M − 1. (13)
Finally, the limits ni are such that for a.e. t ∈ [0, T ]
supp(ni(t, ·)) = arg max
x∈[0,1]
a1(x) for i = 1, . . . ,M. (14)
Proof We divide the proof of Theorem 1 into five parts.
Part 1: Non-negativity of niε(t, x) and continuity of ρiε(t). For all
ε > 0, standard arguments based on the Banach fixed point theorem allow
one to prove that, under assumptions (2)-(4) and (6), the Cauchy problem (7)
admits a solution of non-negative components niε ∈ C([0,∞),L1([0, 1])).
Part 2: Uniform upper bounds for ρiε(t). The following uniform upper
bounds hold
ρiε(t) < ρi for i = 1, . . . ,M, for all t ≥ 0 and for any ε > 0 (15)
with 0 < ρi <∞, the proof of which is provided in Appendix B.
Part 3: Proof of (9). The upper bounds (15) allow us to use the Banach-
Alaoglu theorem to conclude that, up to extraction of subsequences, the asymp-
totic result (9) is verified.
Part 4: Proof of (10) and (11). The asymptotic result (9) on nM ε al-
lows us to conclude that there exists a subsequence of Riε, that we denote
again as Riε, such that
for all (t, x) ∈ [0,∞)× [0, 1] we have Riε(t, x) −−−→
ε→0
Ri(t, x), (16)
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for all i = 1, . . . ,M − 1, where Ri(t, x) is defined according to (11). Further-
more, assumptions (2) and (3) ensure that, for any ε > 0, the function Riε and
its first derivatives with respect to t and x are bounded in L∞ ((0, T )× [0, 1]).
Therefore, Riε belongs to W
1,∞ ((0, T )× [0, 1]) for any ε > 0 and, using the
fact that W1,∞((0, T )× [0, 1]) is compactly embedded in C([0, T ]× [0, 1]), we
conclude that the uniform convergence result (10) is verified.
Part 5: Proof of (12)-(14). We prove the results (12)-(14) in four steps.
Part 5 – Step 1. We prove that
R1(t, x) ≤ 0 for all (t, x) ∈ (0, T )× [0, 1] (17)
and
Ri(t, x) < 0 for all (t, x) ∈ (0, T )× [0, 1], for all i = 2, . . . ,M − 1. (18)
By contradiction, assume that there exists (tˆ, xˆ) ∈ [0, T ] × (0, 1) such that
R1(tˆ, xˆ) > 0. The convergence result (10) for i = 1 implies that R1ε(t, x) ≥ σ
for some σ > 0, as long as |t− tˆ| ≤ σ, |x− xˆ| ≤ σ and σ ≥ ε > 0. Since n01 > 0
on [0, 1] we conclude that∫ 1
0
n1ε(t, x) dx =
∫ 1
0
n01(x) e
R1ε(t,x)
ε dx ≥ eσε
∫ xˆ+σ
xˆ−σ
n01(x) dx −−−→
ε→0
∞
for all t ∈ [tˆ− σ, tˆ+ σ]. This contradicts the upper bound (15) for ρ1ε(t), thus
proving (17). Moreover, such a result on R1 ensures that∫ t
0
P1(ρM (s), x) ds = p1(x)
∫ t
0
(
2 a1(x)
1 +KρM (s)
− 1
)
ds ≤ 0
for all (t, x) ∈ (0, T )× [0, 1] and, since p1 > 0 on [0, 1] [cf. assumption (3)], the
above inequality implies that∫ t
0
(
2 a1(x)
1 +KρM (s)
− 1
)
ds ≤ 0 for all (t, x) ∈ (0, T )× [0, 1].
Since a1(x) > ai(x) for all x ∈ [0, 1] and for all i = 2, . . . ,M−1 [cf. assumption
(4)], the latter inequality allows one to conclude that for all i = 2, . . . ,M − 1∫ t
0
(
2 ai(x)
1 +KρM (s)
− 1
)
ds < 0 for all (t, x) ∈ (0, T )× [0, 1]
and using the fact that pi > 0 on [0, 1] [cf. assumption (3)] one obtains
pi(x)
∫ t
0
(
2 ai(x)
1 +KρM (s)
− 1
)
ds < 0 for all (t, x) ∈ (0, T )× [0, 1]
for all i = 2, . . . ,M − 1. This concludes the proof of (18), which implies
that (13) is verified.
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Part 5 – Step 2. We prove that
if R1(t, ·) < 0 on [0, 1] then ni(t, ·) = 0 a.e. on [0, 1] (19)
for all i = 1, . . . ,M . Throughout this step we consider (tˆ, xˆ) ∈ (0, T ) × (0, 1)
such that R1(tˆ, xˆ) < 0.
Proof of (19) for i = 1. The uniform convergence result (10) for i = 1 ensures
that there exists some σ > 0 such that R1ε(t, x) ≤ −σ for |t−tˆ| ≤ σ, |x−xˆ| ≤ σ
and σ ≥ ε > 0. This allows us to conclude that
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ xˆ+σ
xˆ−σ
n1ε(t, x) dxdt = lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ xˆ+σ
xˆ−σ
n01(x)e
R1ε(t,x)
ε dx dt
≤ 2σ lim
ε→0
e−
σ
ε
∫ xˆ+σ
xˆ−σ
n01(x) dx,
that is,
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ xˆ+σ
xˆ−σ
n1ε(t, x) dx dt = 0. (20)
The weak convergence result (9) for n1ε(t, x) ensures that∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n1(t, x) dxdt = lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n1ε(t, x) dx dt (21)
for every test function ϕ : [0, 1] → R. Therefore, choosing a smooth test
function ϕ that satisfies the following conditions
1[xˆ−σ/2,xˆ+σ/2] ≤ ϕ ≤ 1[xˆ−σ,xˆ+σ], (22)
where 1 denotes the indicator function, and using the fact that n1ε is non-
negative we find∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n1(t, x) dx dt ≤ lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ xˆ+σ
xˆ−σ
n1ε(t, x) dxdt. (23)
Substituting (20) into the latter integral inequality we conclude that
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n1(t, x) dx dt = 0 (24)
for every smooth test function that satisfies (22). Hence, the result (19) for
i = 1 is verified.
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Proof of (19) for i = 2. Multiplying by a test function ϕ : [0, 1] → R both
sides of the IDE (7) for n2ε and integrating over the set [tˆ − σ, tˆ + σ] × [0, 1]
we find
ε
[∫ 1
0
ϕ(x)n2ε(tˆ+ σ, x) dx−
∫ 1
0
ϕ(x)n2ε(tˆ− σ, x) dx
]
=
∫ tˆ+σ
tˆ−σ
∫ 1
0
Q1(ρM ε(t), x)ϕ(x)n1ε(t, x) dxdt
+
∫ tˆ+σ
tˆ−σ
∫ 1
0
P2(ρM ε(t), x)ϕ(x)n2ε(t, x) dx dt.
Since the uniform upper bound (15) for ρ2ε ensures that
lim
ε→0
ε
[∫ 1
0
ϕ(x)n2ε(tˆ+ σ, x) dx−
∫ 1
0
ϕ(x)n2ε(tˆ− σ, x) dx
]
= 0,
we conclude that
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
Q1(ρM ε(t), x)ϕ(x)n1ε(t, x) dxdt
+ lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
P2(ρM ε(t), x)ϕ(x)n2ε(t, x) dxdt = 0.
Choosing a smooth test function that satisfies (22) and using (21) and (24)
along with the fact that Q1(ρM ε(t), x) > 0 on [0, T ]× [0, 1] yields
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
P2(ρM ε(t), x)ϕ(x)n2ε(t, x) dxdt = 0. (25)
Since P2(ρM ε(t), x) < 0 on [0, 1] for a.e. t ∈ (0, T ) when ε → 0, the result
given by (25) allows us to conclude that
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n2ε(t, x) dxdt = 0, (26)
for every smooth test function that satisfies (22). The weak convergence re-
sult (9) for n2ε(t, x) ensures that∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n2(t, x) dxdt = lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n2ε(t, x) dxdt. (27)
Hence, using (26) and (27) we conclude that∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)n2(t, x) dx dt = 0
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for every smooth test function that satisfies (22). Therefore, the result (19) for
i = 2 is verified.
Proof of (19) for all i = 3, . . . ,M − 1. Using a bootstrap argument based on
the method of proof that we have used for the case i = 2, one can prove that
for all i = 3, . . . ,M − 1
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)niε(t, x) dx dt =
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)ni(t, x) dxdt = 0 (28)
for every smooth test function that satisfies (22). Hence, the results (19) for
i = 3, . . . ,M − 1 are verified.
Proof of (19) for i = M . Multiplying by a test function ϕ : [0, 1] → R both
sides of the IDE (7) for nMε and integrating over the set [tˆ− σ, tˆ+ σ]× [0, 1]
we obtain
ε
[∫ 1
0
ϕ(x)nMε(tˆ+ σ, x) dx−
∫ 1
0
ϕ(x)nMε(tˆ− σ, x) dx
]
=
∫ tˆ+σ
tˆ−σ
∫ 1
0
QM−1(ρM ε(t), x)ϕ(x)nM−1ε(t, x) dxdt
− d
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nMε(t, x) dxdt.
Since the uniform upper bound (15) for ρMε ensures that
lim
ε→0
ε
[∫ 1
0
ϕ(x)nMε(tˆ+ σ, x) dx−
∫ 1
0
ϕ(x)nMε(tˆ− σ, x) dx
]
= 0,
we conclude that
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
QM−1(ρM ε(t), x)ϕ(x)nM−1ε(t, x) dxdt
− d lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nMε(t, x) dxdt = 0.
Choosing a smooth test function that satisfies (22) and using the result (28)
for nM−1ε(t, x) along with the fact that QM−1(ρM ε(t), x) > 0 on [0, T ]× [0, 1]
gives
lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nMε(t, x) dxdt = 0. (29)
The weak convergence result (9) for nMε(t, x) ensures that∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nM (t, x) dxdt = lim
ε→0
∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nMε(t, x) dxdt. (30)
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Hence, using (29) and (30) we conclude that∫ tˆ+σ
tˆ−σ
∫ 1
0
ϕ(x)nM (t, x) dx dt = 0
for every smooth test function that satisfies (22). Therefore, the result (19) for
i = M is verified.
Part 5 – Step 3. We prove that
max
x∈[0,1]
R1(t, x) = 0 for any t ∈ [0, T ], (31)
ρ1(t) > 0 a.e. on [0, T ], (32)
and
arg max
x∈[0,1]
R1(t, x) = arg max
x∈[0,1]
a1(x) for any t ∈ [0, T ]. (33)
We begin by noting that, since p1 > 0 on [0, 1], if
max
x∈[0,1]
R1(t, x) = 0
for some t ∈ [0, T ] then [vid. the definition (11) of the function R1]
max
x∈[0,1]
∫ t
0
(
2 a1(x)
1 +KρM (s)
− 1
)
ds = 0
and, therefore,
arg max
x∈[0,1]
R1(t, x) = arg max
x∈[0,1]
a1(x). (34)
Hence, if (31) holds true then (33) is verified.
To prove (31) and (32) we proceed as follows. Assume by contradiction
that there exist tˆ ∈ [0, T ) and σ > 0 with tˆ+ σ ≤ T such that
max
x∈[0,1]
R1(t, x) = 0 ∀t ∈ [0, tˆ] and ρ1(t) > 0 a.e. on [0, tˆ] (35)
whereas
max
x∈[0,1]
R1(t, x) < 0 ∀t ∈ (tˆ, tˆ+ σ). (36)
Under assumptions (35) and (36), the result (19) on nM (t, x) allows one to
conclude that
ρM (t) = 0 for a.e. t ∈ (tˆ, tˆ+ σ). (37)
We take xˆ ∈ arg max
x∈[0,1]
R1(tˆ, x). Using (37) we find that under assumptions (35)
and (36)
R1(tˆ+ σ, xˆ) =
∫ tˆ+σ
0
P1(ρM (t), xˆ) dt = R1(tˆ, xˆ) +
∫ tˆ+σ
tˆ
P1(0, xˆ) dt,
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that is,
R1(tˆ+ σ, xˆ) =
∫ tˆ+σ
tˆ
p1(xˆ)
[
2 a1(xˆ)− 1
]
dt.
Due to assumption (2) this yields R1(tˆ + σ, xˆ) > 0, which contradicts the
result (17) on R1. Hence,
max
x∈[0,1]
R1(t, x) = 0 for any t ∈ (tˆ, tˆ+ σ) and ρ1(t) > 0 a.e on (tˆ, tˆ+ σ)
as well. Therefore, the results (31) and (32) are verified. Hence, both the re-
sult (12) and, under the assumption (6) on n01, the result (14) on the limit n1
hold.
Part 5 – Step 4. To prove the result (14) on the limit n2 we proceed as
follows. The weak convergence result (9) for n1ε along with the result (14) on
the limit n1 and the fact that Q1(ρM ε(t), x) > 0 on [0, T ]× [0, 1] ensures that
for all τ ∈ [0, T ) and for all σ > 0 with τ + σ ≤ T we have
lim
ε→0
∫ τ+σ
τ
∫ 1
0
Q1(ρM ε(t), x)n1ε(t, x) dxdt > 0. (38)
Moreover, integrating over the set [τ, τ + σ]× [0, 1] both sides of the IDE (7)
for n2ε we find
ε
[∫ 1
0
n2ε(τ + σ, x) dx−
∫ 1
0
n2ε(τ, x) dx
]
=
∫ τ+σ
τ
∫ 1
0
Q1(ρM ε(t), x)n1ε(t, x) dxdt
+
∫ τ+σ
τ
∫ 1
0
P2(ρM ε(t), x)n2ε(t, x) dx dt
and, since the upper bound (15) for ρ2ε ensures that
lim
ε→0
ε
[∫ 1
0
n2ε(τ + σ, x) dx−
∫ 1
0
n2ε(τ, x) dx
]
= 0,
we conclude that
lim
ε→0
∫ τ+σ
τ
∫ 1
0
Q1(ρM ε(t), x)n1ε(t, x) dxdt
+ lim
ε→0
∫ τ+σ
τ
∫ 1
0
P2(ρM ε(t), x)n2ε(t, x) dxdt = 0.
This along with (38) implies that
lim
ε→0
∫ τ+σ
τ
∫ 1
0
P2(ρM ε(t), x)n2ε(t, x) dxdt < 0. (39)
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Coherently with the fact that P2(ρM ε(t), x) < 0 on [0, 1] for a.e. t ∈ (0, T )
when ε→ 0, the result given by (39) yields
lim
ε→0
∫ τ+σ
τ
∫ 1
0
n2ε(t, x) dxdt > 0. (40)
This along with the calculations carried out in Part 5 – Step 2 allow us to
conclude that the result (14) on the limit n2 is verified. The results (14) for
the limits ni with i = 3, . . . ,M can be proved in a similar way through a
bootstrap argument.
2
The general asymptotic result established by Theorem 1 put on a rigorous
mathematical basis the idea that clonal selection is driven by the self-renewal
fraction of leukemic stem cells, as exemplified by Corollaries 2-4 given in Sec-
tion 3.2.
3.2 Biological implications of Theorem 1
Building on the ideas presented in previous studies (Stiehl et al., 2015; Stiehl
and Marciniak-Czochra, 2011, 2012), here we focus on the case where there
are M = 3 possible maturation stages, that is, stem cells (i = 1), progenitor
cells (i = 2) and mature cells/leukemic blasts (i = 3).
In this case, Corollary 2 of Theorem 1 shows that if
arg max
x∈[0,1]
a1(x) =
{
x
}
(41)
then in the limit ε→ 0 the population density functions of stem cells n1ε(t, x),
progenitor cells n2ε(t, x) and mature cells/leukemic blasts n3ε(t, x) become
concentrated as Dirac masses centred at the point x. Analogously, Corollary 3
of Theorem 1 shows that if
arg max
x∈[0,1]
a1(x) = {x1, . . . , xN}, (42)
then when ε→ 0 the cell population density functions n1ε(t, x), n2ε(t, x) and
n3ε(t, x) become concentrated as weighted sums of Dirac masses centred at
the points {x1, . . . , xN}. In both cases, the centres of the Dirac masses do not
depend on the functions p1(x), a2(x) and p2(x).
From a biological point of view, the centres of the Dirac masses can be
understood as the leukemic clones that are selected for in the limit of many cell
generations. Therefore, the asymptotic results of Corollary 2 and Corollary 3
formalise the idea that clonal selection is controlled by the self-renewal fraction
of leukemic stem cells, as the leukemic clone(s) with the highest stem cell self-
renewal fraction are ultimately selected.
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The results of Corollary 2 and Corollary 3 are complemented by Corollary 4
of Theorem 1, which shows that if the function a1(x) is constant, i.e. if
a1(x) = A1 ∈ R+ with 1
2
< a2(x) < A1 < 1 for all x ∈ [0, 1], (43)
then in the asymptotic regime ε → 0 the cell population density functions
n1ε(t, x), n2ε(t, x) and n3ε(t, x) do not become concentrated as Dirac masses.
Biologically, this indicates that if the stem cell self-renewal fraction is the same
for all leukemic clones, then clonal selection will not occur and no specific
clones will be selected.
Corollary 2 (Selection of one single clone) Assume M = 3 and let the
assumptions of Theorem 1 along with the additional assumption (41) hold.
Then, the measures n1, n2 and n3 given by Theorem 1 are such that
ni(t, x) = ρi(t) δ(x− x) for a.e. t ∈ [0, T ], for i = 1, 2, 3. (44)
Proof For M = 3, under the additional assumption (41), the result given
by (44) is a straightforward consequence of the general asymptotic result (14).
2
Corollary 3 (Selection of multiple clones) Assume M = 3 and let the
assumptions of Theorem 1 along with the additional assumption (42) hold.
Then, the measures n1, n2 and n3 given by Theorem 1 are such that
ni(t, x) =
N∑
j=1
ρij(t)δ(x− xj) for a.e. t ∈ [0, T ], for i = 1, 2, 3. (45)
Proof For M = 3, under the additional assumption (42), the result given
by (45) is a straightforward consequence of the general asymptotic result (14).
2
Corollary 4 (Absence of clonal selection) AssumeM = 3 and let the as-
sumptions of Theorem 1 along with the additional assumption (43) hold. More-
over, let M = 3. Then, the measures n1, n2 and n3 given by Theorem 1 are
such that
supp(ni(t, ·)) = [0, 1] for a.e. t ∈ [0, T ], for i = 1, 2, 3. (46)
Proof For M = 3, under the additional assumption (43), the result given
by (46) is a straightforward consequence of the general asymptotic result (14).
2
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4 Numerical solutions
We integrate the asymptotic results established by Corollaries 2 - 4 of Theo-
rem 1 with numerical solutions of the Cauchy problem defined by the system
of IDEs (5) with M = 3 complemented with biologically relevant initial con-
ditions (vid. Section 4.2). We parameterise the model based on patient data
from the existing literature (vid. Section 4.1).
4.1 Setup of numerical simulations and model calibration
To construct numerical solutions, we choose a uniform discretisation of the
interval [0, 1] that consists of 1000 points. We assume t ∈ [0, T ] and we approx-
imate the IDE system for the population density functions n1(t, x), n2(t, x)
and n3(t, x) using the forward Euler method with step size 10
−4. We choose
T = 104. Under the parameter settings considered here, such a value of T cor-
responds to a time frame of approximatively 30 years after the appearance of
the first leukemic clones. This is biologically reasonable since acute leukemia
has a pronounced peak of incidence in late adulthood.
Numerical computations are performed in Matlab for two main parameter
settings: one under which the total cell density functions ρ1(t), ρ2(t) and ρ3(t)
converge to some stable values (vid. Section 4.1.1), and the other such that
the total cell density functions undergo oscillations (vid. Section 4.1.2).
4.1.1 Model calibration 1
To model an initial scenario whereby, due to clonal heterogeneity, all possible
leukemic clones are present in small numbers in every maturation compart-
ment, and the total densities of healthy cells are close to the cell counts at
physiological equilibrium, we use the following initial data
n0i (x) = Ni exp
(
− x
2
0.2
)
for i = 1, 2, 3, (47)
with
N1 ≈ 2.5× 107, N2 ≈ 3.8× 109 and N3 ≈ 108. (48)
Such initial conditions satisfy assumptions (6).
Multi-compartment models of hematopoiesis after bone marrow transplan-
tation allow to estimate the proliferation rates and the self-renewal fractions
of healthy stem and progenitor cells, as well as the parameters of the feedback
signal (Stiehl et al., 2015, 2014c). In particular, coherently with the estimations
performed in (Stiehl et al., 2014c), we assume that
a1(0) = 0.85, a2(0) = 0.84, p1(0) = 0.1/day, p2(0) = 0.4/day (49)
and
K = 1.75× 10−9kg/cell. (50)
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Clearance rates of mature cells and leukemic blasts can be estimated based on
patient data and they appear to be between 0.1/day and 2.3/day (Cartwright
et al., 1964; Malinowska et al., 2002; Savitskiy et al., 2003). For this reason,
we choose
d = 2/day. (51)
In agreement with the estimations performed in (Stiehl et al., 2015, 2014c),
which are based on clinical data of blast dynamics in relapsing patients, we
impose the following conditions
0.85 ≤ a1(x) ≤ 0.99 and 0.1/day ≤ p1(x) < 1/day for all x ∈ (0, 1]. (52)
The values of the function a2(x) are constrained by assumption (4). Moreover,
since it is well accepted that stem cells divide at lower rates compared to
progenitor cells (Adams et al., 2015; Cronkite, 1979; Shepherd et al., 2004),
we impose the following additional conditions
0 < p1(x) ≤ p2(x) < 1 for all x ∈ [0, 1]. (53)
We let the continuous structuring variable x parameterise the cell prolifer-
ation rate and we use of the following definitions
p1(x) = α1 + β1 x and p2(x) = α2 + β2 x. (54)
In order to fulfil conditions (49), we choose
α1 = 0.1/day and α2 = 0.4/day. (55)
Moreover, we choose
β1 = 0.2/day and β2 = 0.5/day (56)
so that conditions (52) and (53) are satisfied. To take into account the com-
plex relationship between proliferation and self-renewal observed in leukemic
cells (Doulatov et al., 2009; Ghosh et al., 2016; Kikushige et al., 2015; Lagunas-
Rangel and Cha´vez-Valencia, 2017; Wang et al., 2010; Yassin et al., 2010), we
assume the correspondence between the self-renewal fraction and the cell pro-
liferation rate to be non-bijective and among all possible definitions which
satisfy conditions (4), (49) and (52) we choose
a2(x) = 0.5 exp
[
− (x− 0.4)
2
8.82
]
+ 0.349 (57)
and
a1(x) = exp
[
− (x− 0.6)
2
9.68
]
− 0.1135 (58)
or
a1(x) = a
0
1 + 0.1
4∑
j=1
exp
[
− (x− xj)
2
0.0025
]
(59)
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with
xj ∈ {0.35, 0.55, 0.7, 0.85} and a01 = 0.85− 0.1
4∑
j=1
exp
[
− x
2
j
0.0025
]
, (60)
or
a1(x) ≡ 0.88. (61)
Definition (57) models a biological scenario where the leukemic clone identified
by x = 0.4 has the highest self-renewal fraction among progenitor cells. More-
over, definitions (58), (59)-(60), and (61) model, respectively, three distinct
situations whereby, due to differential gene expression at different maturation
stages:
- the leukemic clone identified by x = 0.6 has the highest self-renewal fraction
among stem cells;
- the leukemic clones corresponding to x = 0.35, x = 0.55, x = 0.7 and
x = 0.85 have the highest self-renewal fraction among stem cells;
- all leukemic clones in the stem-cell compartment have the same self-renewal
fraction.
4.1.2 Model calibration 2
On the basis of considerations analogous to those presented in Section 4.1.1,
we use the initial data (47) with
N1 ≈ 4.37× 106, N2 ≈ 5× 108, N3 ≈ 4.28× 108 (62)
and we choose
K = 1.75× 10−9kg/cell, d = 0.15/day. (63)
Moreover, we define the functions p1(x) and p2(x) according to (54) with
α1 = 0.975/day, α2 = 0.04/day (64)
and
β1 = 0.025/day, β2 = 0.0333/day. (65)
Finally, we assume
a1(x) =
0.7
0.8865
{
exp
[
− (x− 0.6)
2
9.68
]
− 0.1135
}
(66)
and
a2(x) =
0.6
0.8467
{
0.5 exp
[
− (x− 0.4)
2
8.82
]
+ 0.349
}
, (67)
i.e. we consider a biological scenario whereby the leukemic clones identified by
x = 0.6 and x = 0.4 have the highest self-renewal fraction among stem cells
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and progenitor cells, respectively. The parameters and functions (64)-(67) are
such that the values of the functions p1(x), p2(x), a1(x) and a2(x) at the
point x = 0.6 [i.e. the maximum point of the function a1(x)] coincide with the
parameter values for which the solutions of the ODE system (68) with M = 3
are known to undergo periodic oscillations (Knauer, 2012; Knauer et al., 2019).
4.2 Main results
In agreement with the asymptotic results established by Corollary 2 and Corol-
lary 3 of Theorem 1, the numerical solutions presented in Fig. 2 and Fig. 3
show that, under the parameter setting given in Section 4.1.1, the population
density functions of stem cells n1(t, x), progenitor cells n2(t, x) and mature
cells/leukemic blasts n3(t, x) become progressively concentrated at the maxi-
mum point(s) of the function a1(x). Moreover, the plots in the insets of Fig. 2
and Fig. 3 highlight the existence of leukemic clones which grow transiently
before becoming ultimately extinct. Finally, the numerical solutions displayed
in Fig. 4 illustrate how, in agreement with the asymptotic results of Corollary 4
of Theorem 1, if the function a1(x) is constant, the long-term limits of the pop-
ulation density functions n1(t, x), n2(t, x) and n3(t, x) are not concentrated at
any particular point.
As mentioned earlier in the paper, these results communicate the biolog-
ical notion that the self-renewal fraction of leukemic stem cells determines
the fate of clonal selection. In fact, the leukemic clones characterised by the
highest stem cell self-renewal fraction are selected, regardless of their proper-
ties in terms of stem cell proliferation rate, progenitor cell proliferation rate
and progenitor cell self-renewal fraction. This supports the idea that inter-
clonal variability in the self-renewal fraction of leukemic stem cells provides
the necessary substrate for clonal selection to act upon.
Under the parameter setting given in Section 4.1.1, the total density of
stem cells ρ1(t), progenitor cells ρ2(t) and mature cells/leukemic blasts ρ3(t)
converge to some stable values (vid. Fig. 5). However, it is known that for
given parameter choices the solutions of the ODE system (68) with M = 3
undergo periodic oscillations, which result from the occurrence of Hopf bifur-
cation (Knauer, 2012; Knauer et al., 2019). The numerical results presented
in Fig. 7 show that, under the parameter setting given in Section 4.1.2, os-
cillations emerge in the integrals of the solutions to the IDE system (5) with
M = 3 [i.e. in the total cell densities ρ1(t), ρ2(t) and ρ3(t)]. In analogy with
the previous cases, the numerical solutions presented in Fig. 6 indicate that
the cell population density functions n1(t, x), n2(t, x) and n3(t, x) become pro-
gressively concentrated at the maximum point of the function a1(x) – i.e. the
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Fig. 2: Selection of one single clone. Dynamics of the normalised cell
population density functions n1(t, x)/ρ1(t) (left panel), n2(t, x)/ρ2(t) (central
panel) and n3(t, x)/ρ3(t) (right panel) under the parameter setting given in
Section 4.1.1 with a1(x) defined according to (58). The black lines highlight the
clone with the maximum self-renewal fraction in the stem-cell compartment
[i.e. the maximum point of the function a1(x)], while the white lines high-
light the clone with the maximum self-renewal fraction in the progenitor-cell
compartment [i.e. the maximum point of the function a2(x)]. The transient
behaviour of the solutions from the initial conditions is displayed by the plots
in the insets, which show the dynamics of the normalised population density
functions for t ∈ [0, 500]. The colour scale ranges from blue (low density) to
yellow (high density).
Fig. 3: Selection of multiple clones. Dynamics of the normalised cell
population density functions n1(t, x)/ρ1(t) (left panel), n2(t, x)/ρ2(t) (cen-
tral panel) and n3(t, x)/ρ3(t) (right panel) under the parameter setting given
in Section 4.1.1 with a1(x) defined according to (59) and (60). The black
lines highlight the clones with the maximum self-renewal fraction in the stem-
cell compartment [i.e. the maximum points of the function a1(x)], while the
white lines highlight the clone with the maximum self-renewal fraction in the
progenitor-cell compartment [i.e. the maximum point of the function a2(x)].
The transient behaviour of the solutions from the initial conditions is displayed
by the plots in the insets, which show the dynamics of the normalised popula-
tion density functions for t ∈ [0, 200]. The colour scale ranges from blue (low
density) to yellow (high density).
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Fig. 4: Absence of clonal selection. Dynamics of the normalised cell popula-
tion density functions n1(t, x)/ρ1(t) (left panel), n2(t, x)/ρ2(t) (central panel)
and n3(t, x)/ρ3(t) (right panel) under the parameter setting given in Sec-
tion 4.1.1 with a1(x) defined according to (61). The white lines highlight the
clone with the maximum self-renewal fraction in the progenitor-cell compart-
ment [i.e. the maximum point of the function a2(x)]. The colour scale ranges
from blue (low density) to yellow (high density).
Fig. 5: Dynamics of the total cell densities. Left panel. Dynamics of the
total density of stem cells ρ1(t) (blue line), progenitor cells ρ2(t) (red line)
and mature cells/leukemic blasts ρ3(t) (red line) under the parameter setting
given in Section 4.1.1 with a1(x) defined according to (58) (left panel), (59)-
(60) (central panel) and (61) (right panel). Values are in units of 107.
leukemic clone characterised by the highest stem cell self-renewal fraction is
ultimately selected.
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Fig. 6: Clonal selection when the total cell densities undergo os-
cillations. Dynamics of the normalised cell population density functions
n1(t, x)/ρ1(t) (left panel), n2(t, x)/ρ2(t) (central panel) and n3(t, x)/ρ3(t)
(right panel) under the parameter setting given in Section 4.1.2. The black
lines highlight the clone with the maximum self-renewal fraction in the stem-
cell compartment [i.e. the maximum point of the function a1(x)], while the
white lines highlight the clone with the maximum self-renewal fraction in the
progenitor-cell compartment [i.e. the maximum point of the function a2(x)].
The colour scale ranges from blue (low density) to yellow (high density).
Fig. 7: Emergence of oscillations in the total cell densities. Dynamics
of the total density of stem cells ρ1(t) (blue line), progenitor cells ρ2(t) (red
line) and mature cells/leukemic blasts ρ3(t) (red line) under the parameter
setting given in Section 4.1.2. Values are in units of 107.
5 Discussion and conclusions
Recent progress in genetic techniques has shed light on the complex co-evolution
of malignant cell clones in leukemias (Anderson et al., 2011; Belderbos et al.,
2017; Ding et al., 2012; Ley et al., 2008). However, several aspects of clonal
selection still remain unclear. In this work, we have adopted a mathemati-
cal modelling approach to study clonal selection in acute leukemias, with the
aim of supporting a better understanding of the biological mechanisms which
underpin observable clonal dynamics.
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Our model consists of a system of coupled IDEs that describe the dynamics
of cells at different maturation stages – from stem cells through increasingly
mature progenitor cells to mature-cells/blasts – seen as distinct compartments.
Each maturation compartment is structured by a continuous variable that
identifies the clone of the cells. In order to incorporate into our model the high
degree of interclonal heterogeneity which is observed in leukemia patients, we
let the cellular proliferation rate and self-renewal fraction (i.e. the fraction of
progeny cells adopting the same fate as their parent cell) in each maturation
compartment be functions of the structuring variable.
In the framework of this model, we have established a number of analyt-
ical results which give answers to the open questions Q1-Q3 posed in the
introduction of this paper. In summary:
A1 Clonal selection is driven by the self-renewal fraction of leukemic stem cells.
Theorem 1 rigorously shows that all leukemic clones with a non-maximal
stem cell self-renewal fraction ultimately become extinct, independently of
their proliferation rate.
A2 Non-stem cell properties do not have a substantial impact on clonal se-
lection. The result established by Corollary 4 formalises the idea that, in
a scenario where the stem cells of all clones have the same self-renewal
fraction, one should expect the stable coexistence of all clones to occur.
A3 Only the clones whose stem cells are endowed with the highest self-renewal
fraction can stably coexist in the presence of interclonal heterogeneity. Corol-
laries 2 and 3 put on a rigorous basis the notion that the leukemic clones
whose stem cells have the highest self-renewal fraction are ultimately se-
lected.
We have integrated our asymptotic results with numerical solutions of a
calibrated version of the model based on real patient data. In agreement with
the theoretical results by Stiehl et al. (2014a), our numerical results reveal the
existence of leukemic clones which display transient growth before becoming
extinct. Such an emergent behaviour was not captured by the IDE model
considered by Busse et al. (2016), who studied the case where cells of different
clones at the same maturation stage have the same proliferation rate. This
suggests that interclonal heterogeneity in the cell proliferation rate may have
an impact on transient clonal dynamics.
It has been shown using genetic techniques that, in most leukemia patients,
the majority of leukemic cells is derived from a relatively small number of
clones (Anderson et al., 2011; Ding et al., 2012). Our results indicate that this
may be due to the fact that only a few leukemic clones are characterised by a
high stem cell self-renewal fraction.
There is accumulating experimental evidence that many of the different
genetic mutations involved in the development of leukemia increase the cell
self-renewal. Possible examples include the TIM-3/Gal-9 autocrine stimula-
tion (Kikushige et al., 2015) or alterations of Wnt/β-Catenin signalling (Wang
et al., 2010). Moreover, it has been shown that genetic mutations can simul-
taneously affect the self-renewal and proliferation of cells due to crosstalk
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between different signalling pathways. For instance, the NUP98-Ddx10 onco-
gene increases both cell proliferation and self-renewal (Yassin et al., 2010);
hyperactivation of the mTOR pathway leads to S6K1-mediated increase in
self-renewal and reduction in proliferation (Ghosh et al., 2016); up-regulation
of PLZF brings about increased self-renewal and reduced proliferation (Doula-
tov et al., 2009). The outcome of our analysis, which ascribes a pivotal role
to increased self-renewal in orchestrating clonal selection, is in line with the
observation that all the aforementioned genetic alterations lead to increased
self-renewal, whereas they have divergent effects on cell proliferation.
The result that clonal selection is not influenced by progenitor cell proper-
ties is biologically meaningful, since it implies that mutations which affect only
the properties of progenitor cells without altering the properties of stem cells
cannot lead to the selection of leukemic clones. This result is new and not self-
evident, as progenitor cells can expand independently of the influx from the
stem cell compartment – although they possess smaller self-renewal fractions
than stem cells (Roelofs et al., 2003; Stiehl et al., 2014c; Yamamoto et al.,
2013). This insight is also clinically relevant. In fact, although it is known that
progenitor cells are more sensitive to treatment interventions than stem cells,
which are located in protective niches, our results suggest that manipulations
of progenitor cells have no impact on clonal selection phenomena.
A rigorous mathematical understanding of clonal selection is needed since
the potentially nonlinear interplay between different genetic and epigenetic
hits (Bacher et al., 2008; Gale et al., 2008; Heuser et al., 2009) leads to com-
plex fitness landscapes and non-trivial interdependencies between self-renewal
fraction and proliferation rate of leukemic cells. In particular, there is evi-
dence that combinations of leukemic mutations occur frequently in patients
(Naoe and Kiyoi, 2013; Pui et al., 2015). An in silico approach can help to
disentangle the impact of different mutations on the properties of leukemic
stem cells. In this regard, our modelling approach can be further developed
in several directions. For instance, in line with what was done for the ODE
counterpart of the model presented here (Stiehl et al., 2014a, 2016, 2018), we
plan to extend our model to take into account the effect of multiple feedback
mechanisms and incorporate the occurrence of de novo mutations. Moreover,
along the lines of the modelling method proposed by Doumic et al. (Doumic-
Jauffret et al., 2011; Gwiazda et al., 2012), it may be interesting to replace
the discrete maturation structure considered in this work by a continuous age
structure, which would lead to the definition of a fully-continuously structured
population model of clonal selection in acute leukemias. From a mathematical
point of view, we also plan to carry out a systematic investigation of the con-
ditions for the emergence of oscillations in the total cell densities, as shown by
our numerical solutions.
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A Multi-compartmental ODE model
In a number of previous papers (Stiehl et al., 2014a, 2015, 2018, 2016; Stiehl and Marciniak-
Czochra, 2012), it was shown that mathematical models defined in the framework of the
following ODE system can effectively recapitulate clinical data from leukemia patients

d
dt
Nj1 (t) =
(
2 aj1
1 +K ZM (t)
− 1
)
pj1N
j
1 (t),
d
dt
Nji (t) = 2
(
1− a
j
i−1
1 +K ZM (t)
)
pji−1N
j
i−1(t)
+
(
2 aji
1 +K ZM (t)
− 1
)
pji N
j
i (t),
d
dt
NjM (t) = 2
(
1− a
j
M−1
1 +K ZM (t)
)
pjM−1N
j
M−1(t)− dNjM (t),
(68)
with i = 2, . . . ,M − 1, j = 0, . . . , J and ZM (t) =
J∑
j=0
NjM (t).
The index i denotes the cell maturation stage while the index j indicates to which
leukemic clone the cells belong. In particular, the stem-cell compartment is labelled by the
index i = 1, the indices i = 2, . . . ,M − 1 correspond to increasingly mature progenitor-
cell compartments and the mature-cell/blast compartment is labelled by the index i = M .
Moreover, the index j = 0 refers to healthy cells, whereas the different leukemic clones are
labelled by the indices j = 1, . . . , J .
In the system of ODEs (68), the function Nji (t) models the density of cells of clone j
at the maturation stage i at the time instant t ≥ 0. Cells in the compartment i = M do
not divide and are cleared from the system at rate d > 0, which is assumed to be the same
for healthy and leukemic cells (Busse et al., 2016; Malinowska et al., 2002; Savitskiy et al.,
2003; Stiehl et al., 2014a, 2018). The parameters pji > 0 and a
j
i > 0 model, respectively, the
proliferation rate and the self-renewal fraction of cells of clone j at the maturation stage i.
Coherently with biological findings (Kondo et al., 1991; Layton et al., 1989; Shinjo et al.,
1997), the terms aji are multiplied by the factor
1
1+KZM (t)
to model the fact that the signal
which promotes the self-renewal of dividing cells is absorbed by mature cells and leukemic
blasts at a rate that depends on the total density of these cells ZM (t). The parameter K > 0
is related to the degradation rate of the feedback signal by mature cells and leukemic blasts.
This has proved to be a biologically consistent way of modelling the effects of feedback
signals that control cell self-renewal (Marciniak-Czochra et al., 2009; Stiehl et al., 2014c,
2018; Stiehl and Marciniak-Czochra, 2011, 2012). In principle, the effects of feedback signals
that control cell proliferation could also be included. However, it has been demonstrated
that such signals have little impact on the dynamics of the blood system (Marciniak-Czochra
et al., 2009; Stiehl et al., 2014b,c).
A version of the ODE model (68) with only one leukemic clone and three maturation
stages (i.e. M = 3 and J = 1) has been fully analysed by Stiehl and Marciniak-Czochra
(2012), while a two compartmental version of the model for healthy hematopoiesis (i.e.
M = 2 and J = 0) has been analysed by Getto et al. (2013); Nakata et al. (2012); Stiehl and
Marciniak-Czochra (2011). Possible applications of this model to clinical data can be found
in the works by Stiehl et al. (2014a, 2015), whereas applications to healthy hematopoiesis are
provided in the publications by Stiehl et al. (2014b,c). Finally, a version of this model with
a continuous differentiation structure has been proposed and studied by Doumic-Jauffret
et al. (2011).
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B Proof of the uniform upper bounds (15)
In this appendix we prove the upper bounds (15) through a suitable development of the
method of proof presented in (Busse et al., 2016). Using the system of IDEs (7), straight-
forward calculations give the following ODEs
ε
d
dt
ρ1 ε
ρ2 ε
=
1
ρ2 ε
∫ 1
0
P1(ρMε(t), x)n1ε dx
−ρ1 ε
ρ22 ε
∫ 1
0
Q1(ρMε(t), x)n1ε dx− ρ1 ε
ρ22 ε
∫ 1
0
P2(ρMε(t), x)n2ε dx, (69)
ε
d
dt
ρi ε
ρi+1 ε
=
1
ρi+1 ε
∫ 1
0
Qi−1(ρMε(t), x)ni−1ε dx+
1
ρi+1 ε
∫ 1
0
Pi(ρMε(t), x)niε dx
− ρi ε
ρ2i+1 ε
∫ 1
0
Qi(ρMε(t), x)niε dx
− ρi ε
ρ2i+1 ε
∫ 1
0
Pi+1(ρMε(t), x)ni+1ε dx, for i = 2, . . . ,M − 2 (70)
and
ε
d
dt
ρM−1 ε
ρM ε
=
1
ρM ε
∫ 1
0
QM−2(ρMε(t), x)nM−2ε dx+
1
ρM ε
∫ 1
0
PM−1(ρMε(t), x)nM−1ε dx
−ρM−1 ε
ρ2M ε
∫ 1
0
QM−1(ρMε(t), x)nM−1ε dx+ d
ρM−1 ε
ρM ε
. (71)
Under assumptions (2)-(4), for all i = 1, . . . ,M − 1 we have
Pi(ρM ε(t), x) > −‖pi‖L∞([0,1]), Pi(ρM ε(t), x) ≤ 2 ‖ai‖L∞([0,1])‖pi‖L∞([0,1]) =: P i,
and
Qi(ρM ε(t), x) ≥ 2
(
1− ‖ai‖L∞([0,1])
)
inf
x∈[0,1]
pi =: Qi > 0, Qi(ρM ε(t), x) ≤ 2 ‖pi‖L∞([0,1]),
for all t ≥ 0 and all x ∈ [0, 1]. Hence, estimating from above the right-hand sides of the
ODEs (69)-(71) using the above estimates on Pi and Qi along with the non-negativity of
ni ε and ρi ε for all i = 1, . . . ,M gives the following differential inequalities
ε
d
dt
ρ1 ε
ρ2 ε
≤ P 1 ρ1 ε
ρ2 ε
−Q
1
ρ21 ε
ρ22 ε
+ ‖p2‖L∞([0,1])
ρ1 ε
ρ2 ε
≤
[(
P 1 + ‖p2‖L∞([0,1])
)−Q
1
ρ1 ε
ρ2 ε
]
ρ1 ε
ρ2 ε
, (72)
ε
d
dt
ρi ε
ρi+1 ε
≤ 2 ‖pi−1‖L∞([0,1])
ρi−1 ε
ρi+1 ε
+ P i
ρi ε
ρi+1 ε
−Q
i
ρ2i ε
ρ2i+1 ε
+ ‖pi+1‖L∞([0,1])
ρi ε
ρi+1 ε
≤
[(
2 ‖pi−1‖L∞([0,1])
ρi−1 ε
ρi ε
+ P i + ‖pi+1‖L∞([0,1])
)
−Q
i
ρi ε
ρi+1 ε
]
ρi ε
ρi+1 ε
(73)
for i = 2, . . . ,M − 2,
ε
d
dt
ρM−1 ε
ρM ε
≤ 2 ‖pM−2‖L∞([0,1])
ρM−2 ε
ρM ε
+ PM−1
ρM−1 ε
ρM ε
−Q
M−1
ρ2M−1 ε
ρ2M ε
+ d
ρM−1 ε
ρM ε
≤
[(
2 ‖pM−2‖L∞([0,1])
ρM−2 ε
ρM−1 ε
+ PM−1 + d
)
−Q
M−1
ρM−1 ε
ρM ε
]
ρM−1 ε
ρM ε
. (74)
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The differential inequality (72) yields
ρ1 ε(t)
ρ2 ε(t)
≤ max
(
‖n01‖L∞([0,1])
‖n02‖L∞([0,1])
,
P 1 + ‖p2‖L∞([0,1])
Q
1
)
=: B1, (75)
for all t ≥ 0. Substituting the estimate (75) into the differential inequality (73) for i = 2 we
find
ρ2 ε(t)
ρ3 ε(t)
≤ max
(
‖n02‖L∞([0,1])
‖n03‖L∞([0,1])
,
2 ‖p1‖L∞([0,1])B1 + P 2 + ‖p3‖L∞([0,1])
Q
2
)
=: B2, (76)
for all t ≥ 0. In a similar way, substituting the estimate (76) into the differential inequal-
ity (73) for i = 3 gives
ρ3 ε(t)
ρ4 ε(t)
≤ max
(
‖n03‖L∞([0,1])
‖n04‖L∞([0,1])
,
2 ‖p2‖L∞([0,1])B2 + P 3 + ‖p4‖L∞([0,1])
Q
3
)
=: B3, (77)
for all t ≥ 0. Using a bootstrap argument based on the method of proof that we have used
for the case i = 3, one can prove that
ρi ε(t)
ρi+1 ε(t)
≤ max
(
‖n0i ‖L∞([0,1])
‖n0i+1‖L∞([0,1])
,
2 ‖pi−1‖L∞([0,1])Bi−1 + P i + ‖pi+1‖L∞([0,1])
Q
i
)
=: Bi,
(78)
for all t ≥ 0 and for all i = 4, . . . ,M − 2. Finally, substituting the estimate (78) with
i = M − 2 into the differential inequality (74) we obtain
ρM−1 ε(t)
ρM ε(t)
≤ max
(‖n0M−1‖L∞([0,1])
‖n0M‖L∞([0,1])
,
2 ‖pM−2‖L∞([0,1])BM−2 + PM−1 + d
Q
M−1
)
=: BM−1
(79)
for all t ≥ 0. Combining the estimates (75)-(79) yields
ρi ε(t) ≤ ρM ε(t)Ai with Ai :=
M−1∏
k=i
Bk > 0 for i = 1, . . . ,M − 1
for all t ≥ 0, which allows us to conclude that
Pi(ρMε(t), x) ≤
(
2 ai(x)
1 + K
Ai
ρiε(t)
− 1
)
pi(x) for i = 1, . . . ,M − 1
for all t ≥ 0 and all x ∈ [0, 1]. The latter inequality ensures that Pi(ρMε(t), x) satisfies the
following relations for all t ≥ 0 and each i = 1, . . . ,M − 1
if ρiε(t) ≤ Ai
K
(
2 ‖ai‖L∞([0,1]) − 1
)
then
0 ≤ ‖Pi(ρMε(t), ·)‖L∞([0,1]) ≤
(
2 ‖ai‖L∞([0,1])
1 + K
Ai
ρiε(t)
− 1
)
‖pi‖L∞([0,1]) (80)
while
if ρiε(t) >
Ai
K
(
2 ‖ai‖L∞([0,1]) − 1
)
then
‖Pi(ρMε(t), ·)‖L∞([0,1]) ≤
(
2 ‖ai‖L∞([0,1])
1 + K
Ai
ρiε(t)
− 1
)
inf
x∈[0,1]
pi < 0. (81)
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Integrating over [0, 1] both sides of the IDEs (7) for n1 ε and estimating from above
gives the following differential inequality
ε
d
dt
ρ1 ε(t) ≤ ‖P1(ρMε(t), ·)‖L∞([0,1]) ρ1 ε(t) (82)
from which, using (80) and (81) with i = 1, we find that for any ε > 0
ρ1 ε(t) ≤ max
(
‖n01‖L∞([0,1]),
A1
K
(
2 ‖a1‖L∞([0,1]) − 1
))
=: ρ1 for all t ≥ 0,
that is, the upper bound (15) on ρ1 ε is verified.
Furthermore, integrating over [0, 1] both sides of the IDEs (7) for n2 ε and estimating
from above using the fact that
Q1(ρM ε(t), x) ≤ 2 ‖p1‖L∞([0,1]) for all (t, x) ∈ [0,∞)× [0, 1]
along with the upper bound (15) on ρ1 ε gives
ε
d
dt
ρ2 ε(t) ≤ 2 ‖p1‖L∞([0,1])ρ1 + ‖P2(ρMε(t), ·)‖L∞([0,1]) ρ2 ε(t). (83)
The above differential inequality along with the estimates (80) and (81) with i = 2 ensures
that there exists C > 0 such that for any ε > 0
ρ2 ε(t) ≤ max
(
‖n02‖L∞([0,1]),
A2
K
(
2 ‖a2‖L∞([0,1]) − 1
)
,
2
C
‖p1‖L∞([0,1]) ρ1
)
=: ρ2
for all t ≥ 0. Hence, the upper bound (15) on ρ2 ε is verified. The upper bounds (15) on ρi ε
for i = 3, . . . ,M − 1 can be proved in a similar way using a bootstrap argument.
Finally, integrating over [0, 1] both sides of the IDEs (7) for nM ε and estimating from
above using the fact that
QM−1(ρM ε(t), x) ≤ 2 ‖pM−1‖L∞([0,1]) for all (t, x) ∈ [0,∞)× [0, 1]
along with the upper bound (15) on ρM−1 ε gives the following differential inequality
ε
d
dt
ρM ε(t) ≤ 2 ‖pM−1‖L∞([0,1])ρM−1 − d ρMε(t),
which ensures that for any ε > 0 we have
ρM ε(t) ≤ max
(
‖n0M‖L∞([0,1]),
2
d
‖pM−1‖L∞([0,1]) ρM−1
)
=: ρM for all t ≥ 0,
that is, the upper bound (15) on ρM ε is verified.
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